calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,415 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,415 8k filing · 2,000 device pma
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR
Sponsor: PFIZER. Form: SWAB. Route: TOPICAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: MYLAN INSTITUTIONAL. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: OZANTRI. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: LEO PHARMA AS. Form: OINTMENT. Route: TOPICAL
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: ADVANZ PHARMA. Form: GEL. Route: TOPICAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL